Litmus Health

Austin, United States Founded: 2014 • Age: 12 yrs
Data from wearables is leveraged for clinical trial decisions.

About Litmus Health

Litmus Health is a Healthcare company based in Austin (United States) founded in 2014. Data from wearables is leveraged for clinical trial decisions. Litmus Health offers products and services including Patient Apps, Study Hub, and Litmus ML. Its focus areas include Biopharma Outsourcing, CRO, Diversified and Siteless CRO. Its competitors include Culmination Bio, Avacare and Center Point Clinical Services; 1 of its 3 listed competitors has raised funding.

Company details

Litmus Health has developed a data science platform that collects information about patients behavior and environment, runs algorithms (using machine learning and big data analytics) on the data that is collected and summarizes the data for sponsors and researchers via an interactive dashboard. The company also offers Android and iOS patient trial companion apps which can be connected to third party devices and also for conducting validated surveys. The company is primarily targeting clinical trials focused on complex chronic inflammatory diseases like systemic lupus erythematosus, multiple sclerosis, and rheumatoid arthritis as they involve a combination of lifestyle, behavioral, and genetic factors and require quality of life considerations that can be measured and quantified through their platform. The platform conforms to HIPAA guidelines and the data are collected and stored in compliance with 21 CFR Part 11 standards.

  • Headquarters Austin, United States
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website litmushealth.com
  • Social LinkedIn X
Key Metrics
  • Latest Funding Round
    $224.76K (USD), Grant

    Nov 2018

  • Investors

Products & Services of Litmus Health

Litmus Health offers a comprehensive portfolio of products and services, including Patient Apps, Study Hub, and Litmus ML.

Patient Apps
Mobile Application

Apps for collecting patient data and surveys in studies

Study Hub
Monitoring Platform

Platform to track study progress and visualize trends

Litmus ML
Data Analytics

Tool for modeling and predicting health outcomes from data

Funding Insights of Litmus Health

  • Total Rounds 1
  • Last Round Grant β€” $224,759
  • First Round $224,759

    (Nov 2018)

  • Investors Count 1

All 1 funding rounds of Litmus Health with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Nov 2018$224,759Grant––
Valuation history

1 investors in total: 1 institutional.

Investors in Litmus Health

Litmus Health has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include SBIR.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Federal innovation and scientific achievement services are provided.
1982sbir.govLithia Springs, United States
Premium access

Investor details for Litmus Health

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Litmus Health

9 people are tracked at Litmus Health (3 in leadership, 6 in board & advisors).

NameRoleGroup
Sam Volchenboum
Co-Founder, Chief Medical OfficerLeadership
Daphne Kis
Co-Founder, Business & OperationsLeadership
Josh Jones-Dilworth
CEOLeadership
Sam Blackman
Board MemberBoard & advisors
Ian Foster
Board MemberBoard & advisors
Richard Schwartz
Board MemberBoard & advisors
Rebecca Kush
Board MemberBoard & advisors
Esther Dyson
Board MemberBoard & advisors
David Rubin
Board MemberBoard & advisors
Premium access

Complete people profiles for Litmus Health

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Litmus Health

2 dated milestones of Litmus Health across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded Litmus Health is founded.
  2. Funding First funding round of $225K.

Competitors of Litmus Health

Litmus Health has 3 listed competitors in our database, 1 of them funded. They include Culmination Bio, Avacare and Center Point Clinical Services.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
culmination.com2022St. George, United States$10M1
Novel therapeutics are developed and clinical data services are provided.
avacare.com2002Danbury, United States1
Provides clinical trial management services for sponsors, sites, and patients globally.
centerpointclinicalservices.com2013Malvern, United States
Offers siteless CRO and pharmacist-led solutions for clinical trials management.
Premium access

Detailed competitors of Litmus Health

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Litmus Health

The website of Litmus Health (litmushealth.com) receives about 1.4K visits a month.

  • Monthly visits
    1.4K

    ▲ 39.9% vs previous month

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Litmus Health (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M5,666
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Litmus Health

Premium access

Complete news archive for Litmus Health

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Litmus Health

Litmus Health was founded in 2014 and raised its 1st funding round 4 years after it was founded.

Litmus Health is headquartered in Austin, United States. It is registered at Austin, Texas, United States.

Litmus Health has developed a data science platform that collects information about patients behavior and environment, runs algorithms (using machine learning and big data analytics) on the data that is collected and summarizes the data for sponsors and researchers via an interactive dashboard. The company also offers Android and iOS patient trial companion apps which can be connected to third party devices and also for conducting validated surveys. The company is primarily targeting clinical trials focused on complex chronic inflammatory diseases like systemic lupus erythematosus, multiple sclerosis, and rheumatoid arthritis as they involve a combination of lifestyle, behavioral, and genetic factors and require quality of life considerations that can be measured and quantified through their platform. The platform conforms to HIPAA guidelines and the data are collected and stored in compliance with 21 CFR Part 11 standards.

Litmus Health's top competitors include Culmination Bio, Avacare and Center Point Clinical Services.

Litmus Health offers Patient Apps, Study Hub, and Litmus ML.

Litmus Health has 1 investor. Key investors include SBIR.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available